More on ORMP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.62 |
|
|||
| Open | $4.70 | ||||
| 52 Wk High | $10.74 | ||||
| 52 Wk Low | $5.60 | ||||
| Day High | $4.77 | ||||
| Day Low | $4.65 | ||||
| P/E | N/A | ||||
| EPS | $-0.59 | ||||
| Volume | 103,752 | ||||
- Form 8-K ORAMED PHARMACEUTICALS For: Sep 15
- Nano Dimension names Nadav Kidron to board, to chair new committee
- Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
- Form SCHEDULE 13G/A ORAMED PHARMACEUTICALS Filed by: Aquamarine Financial (Cayman) Ltd
- Form 10-Q ORAMED PHARMACEUTICALS For: Jun 30
- Form ARS ORAMED PHARMACEUTICALS For: Dec 31
- Form DEFA14A ORAMED PHARMACEUTICALS
- Form DEF 14A ORAMED PHARMACEUTICALS For: Sep 15
- Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones
- Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
Entities mentioned with ORMP
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Dividend | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
